US 8,513,202 B2
Crystalline form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate
Log In
Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

General

US 8,513,202 B2
Crystalline form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
Eric S Olson
Art Unit:
1623 Organic Chemistry
Inventors:
Sumihiro Nomura; Eiji Kawanishi
Priority:
12/04/06
Filed:
05/09/11
Granted:
08/20/13
Expiration:
12/04/26
Abstract
A novel crystal form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate, and having favorable characteristics, is characterized by its x-ray powder diffraction pattern and/or by its infra-red spectrum.
Cooperative Patent Classification (CPC)
A61A61P17/02A61K31/7034A61PC07H7/04C07H

Analytics

Cases

Patent Assignments

Citations